Development Level

Tbio 6 | 11,178
Tclin 6 | 612
Tdark 5 | 6,569
Tchem 3 | 1,885

IMPC Phenotype

abnormal bone structure 1 | 187
abnormal embryo size 1 | 220
abnormal midbrain development 1 | 20
abnormal neural tube closure 1 | 46
decreased bone mineral content 1 | 151
embryonic growth retardation 1 | 106
embryonic lethality prior to t... 1 | 278
preweaning lethality, complete... 1 | 979
small superior vagus ganglion 1 | 74

Disease

Carcinoma 13 | 11,192
Schizophrenia 11 | 1,136
glioblastoma 11 | 5,635
atypical teratoid / rhabdoid tumor 10 | 4,971
Alcoholic Intoxication, Chronic 9 | 283
Astrocytoma, Pilocytic 9 | 3,006
Depressive disorder 9 | 401
adult high grade glioma 9 | 3,701
oligodendroglioma 9 | 2,768
Cocaine-Related Disorders 8 | 90
Mental Depression 8 | 325
Parkinson's disease 8 | 378
astrocytic glioma 8 | 2,530
medulloblastoma, large-cell 8 | 6,086
Alcohol dependence 7 | 107
Autistic Disorder 7 | 358
Bipolar Disorder 7 | 646
Breast cancer 7 | 3,469
primitive neuroectodermal tumor 7 | 2,957
psoriasis 7 | 6,514
Attention deficit hyperactivity disorder 6 | 272
Major Depressive Disorder 6 | 293
Seizures 6 | 584
Substance abuse 6 | 58
Unipolar Depression 6 | 244
ependymoma 6 | 4,559
group 3 medulloblastoma 6 | 4,002
osteosarcoma 6 | 7,766
Amphetamine-Related Disorders 5 | 72
Kidney cancer 5 | 2,548
Mood Disorders 5 | 181
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,204
invasive ductal carcinoma 5 | 2,867
lung cancer 5 | 4,607
ovarian cancer 5 | 8,297
Alcohol abuse 4 | 48
Chronic schizophrenia 4 | 14
Cocaine Dependence 4 | 51
Dyskinesia, Drug-Induced 4 | 14
Gilles de la Tourette syndrome 4 | 46
Heroin dependence 4 | 30
Huntington's disease 4 | 75
Hyperactive behavior 4 | 90
Hyperkinesis 4 | 31
Opiate dependence 4 | 29
Pathological gambling 4 | 15
Pick disease 4 | 1,856
colon cancer 4 | 1,428
interstitial cystitis 4 | 2,237
intraductal papillary-mucinous adenoma (IPMA) 4 | 2,872
lung carcinoma 4 | 2,755
malignant mesothelioma 4 | 3,135
pancreatic cancer 4 | 2,322
Alcoholism 3 | 45
Alzheimer's disease 3 | 640
Amyotrophic lateral sclerosis 3 | 437
Autosomal recessive predisposition 3 | 1,407
Basal Ganglia Diseases 3 | 14
Brain disease 3 | 95
Cancer 3 | 2,388
Catalepsy 3 | 15
Dementia 3 | 172
Dyskinesias 3 | 6
Dyskinetic syndrome 3 | 15
General anesthesia 3 | 53
Hyperprolactinemia 3 | 27
Movement Disorders 3 | 54
Nausea and vomiting 3 | 93
Neurodegenerative disease 3 | 402
Obesity 3 | 655
Parkinson Disease 3 | 64
Psychotic disorder 3 | 6
Recurrent depression 3 | 9
Schizoaffective Disorder 3 | 55
breast carcinoma 3 | 1,589
cystic fibrosis 3 | 1,629
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,902
obsessive-compulsive disorder 3 | 61
tuberculosis 3 | 1,963
Acute intermittent porphyria 2 | 14
Agoraphobia 2 | 20
Attention Deficit Disorder with Hyperactivity 2 | 21
Bipolar disorder in remission 2 | 19
Cocaine abuse 2 | 18
Delusional disorder 2 | 13
Gastroesophageal reflux disease 2 | 108
Hallucinations 2 | 33
Hyperalgesia 2 | 80
Itching of skin 2 | 18
Liver cancer 2 | 589
Melanoma 2 | 689
Myoclonus 2 | 71
Nasal congestion 2 | 23
Parkinsonian Disorders 2 | 55
Parkinsonism 2 | 18
Restless legs 2 | 4
Toxic encephalopathy 2 | 139
Vomiting 2 | 116
posterior fossa group A ependymoma 2 | 456
posterior fossa group B ependymoma 2 | 406

Tissue

Endocrine System 17 | 18,159
Female tissues 14 | 17,400
Skin and soft tissues 14 | 17,230
Blood and immune system 13 | 16,909
Digestive Tract 13 | 17,369
Male tissues 13 | 17,142
Nervous System 13 | 16,725
Respiratory system 13 | 16,393
Cardiovascular System 12 | 15,192
Liver and Pancreas 12 | 16,750
Urinary Tract 11 | 16,678

Target Family

GPCR 6 | 408
Non-IDG 5 | 12,091
oGPCR 5 | 421
Enzyme 2 | 4,145
Kinase 2 | 634

GO Process

behavioral response to cocaine 20 | 20
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Olfactory receptor 56A5 OR56A5 Tdark oGPCR 0.00000 0
D(1A) dopamine receptor DRD1 Tclin GPCR -2.55049 294.2 485
Kappa-type opioid receptor OPRK1 Tclin GPCR -2.49945 308.5 283
5-hydroxytryptamine receptor 2A HTR2A Tclin GPCR -3.33563 2152.8 231
Olfactory receptor 56A4 OR56A4 Tdark oGPCR 0.00000 8
Olfactory receptor 56A1 OR56A1 Tdark oGPCR 0.00000 73
Olfactory receptor 5T1 OR5T1 Tdark oGPCR 0.00000 9
D(3) dopamine receptor DRD3 Tclin GPCR -2.51699 312.3 189
Protein sidekick-1 SDK1 Tbio Non-IDG -0.91335 10.7 24
Olfactory receptor 13F1 OR13F1 Tdark oGPCR 0.00000 69